Genomic newborn screening: ICoNS
Gene: ACADM
Well established gene-disease association.
Inherited deficiency of medium-chain acyl-CoA dehydrogenase is characterized by intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels. Can be severe, potentially fatal.
Typical presentation is between 3 and 24 months.
More than 98% of cases of MCAD deficiency have a pathogenic variant in ACADM, with the c.985A>G variant accounting for between 56-91% of cases.
Treatment: management plan to avoid fasting.
ClinGen: Strong Actionability in paediatric patients.
Non-genetic confirmatory tests: Urine acylglycine analysis
Included in BabyScreen+, BabySeq, BeginNGS, Guardian, Generation, EarlyCheck
Sources: Expert listCreated: 20 May 2025, 4:35 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Acyl-CoA dehydrogenase, medium chain, deficiency of MIM# 201450
Gene: acadm has been classified as Green List (High Evidence).
Gene: acadm has been classified as Green List (High Evidence).
gene: ACADM was added gene: ACADM was added to Genomic newborn screening: ICoNS. Sources: Expert list Mode of inheritance for gene: ACADM was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: ACADM were set to Acyl-CoA dehydrogenase, medium chain, deficiency of MIM# 201450 Review for gene: ACADM was set to GREEN